Scientists At University Of Munich Publish New Data On Colon Cancer

This news article has expired. Below you will find a short description about the news article and comments that were left by CancerCompass users.

The benefit of elective primary tumor resection for non-curable stage IV colorectal cancer (CRC) remains largely undefined. We wanted to identify risk factors for postoperative complications and short survival, scientists in Munich, Germany report.

 

0 Comments

You must be logged in to post comments.

We care about your feedback. Let us know how we can improve your CancerCompass experience.